optic atrophy 11

Rare Disease

MONDO:0015011

Also known as:

OPA11YME1L1 autosomal recessive isolated optic atrophyautosomal recessive isolated optic atrophy caused by mutation in YME1L1

Any autosomal recessive isolated optic atrophy in which the cause of the disease is a mutation in the YME1L1 gene.

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases

Companies Active in optic atrophy 11

1 company

Organizations with orphan designations or approved therapies for this disease

Rigel Pharmaceuticals, Inc.

Other

Designated

View all companies

optic atrophy 11

Patient-Friendly Information

Need this data in your product?

Scientific Intelligence

Companies Active in optic atrophy 11